U.S., May 7 -- ClinicalTrials.gov registry received information related to the study (NCT06958614) titled 'Prophylactic PEG-rhG-CSF During cCRT in LA-NSCLC' on March 28.
Brief Summary: Objective: To evaluate the efficacy and safety of prophylactic use of pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) during definitive concurrent chemoradiotherapy (cCRT) in patients with inoperable stage II-III non-small cell lung cancer (NSCLC).
Methods: A prospective observational cohort study was conducted on patients receiving definitive cCRT. The radiation therapy technique uses intensity modulated radiation therapy (IMRT) and involves field irradiation. It protects more normal tissue from exposure.Chemotherapy regimen...